- Home
- CRMD vs NAGE Comparison
CRMD vs NAGE Comparison
Compare CRMD & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRMD | NAGE |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 943.9M | 766.4M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRMD | NAGE |
|---|---|---|
| Price | $12.05 | $6.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $17.43 | $16.33 |
| AVG Volume (30 Days) | ★ 2.6M | 724.9K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1093.81 |
| EPS | ★ 2.25 | 0.23 |
| Revenue | ★ $214,303,672.00 | $124,709,000.00 |
| Revenue This Year | $627.89 | $30.37 |
| Revenue Next Year | $40.95 | $20.36 |
| P/E Ratio | ★ $5.41 | $28.14 |
| Revenue Growth | ★ 1647.67 | 36.04 |
| 52 Week Low | $5.60 | $5.16 |
| 52 Week High | $17.43 | $14.69 |
Technical Indicators
Market Signals| Indicator | CRMD | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 63.43 | 47.88 |
| Support Level | $11.78 | $6.40 |
| Resistance Level | $12.51 | $7.06 |
| Average True Range (ATR) | 0.51 | 0.23 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 85.18 | 45.73 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.